Obstructive sleep apnoea syndrome – an oxidative stress disorder

Lavie, 2000, Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study, BMJ, 320, 479, 10.1136/bmj.320.7233.479

Grote, 2000, Sleep-related breathing disorder is an independent factor for uncontrolled hypertension, J Hypertens, 18, 679, 10.1097/00004872-200018060-00004

Shahar, 2001, Sleep-disordered breathing and cardiovascular disease cross-sectional results of the Sleep Heart Health Study, Am J Respir Crit Care Med, 163, 19, 10.1164/ajrccm.163.1.2001008

Young, 1997, Population-based study of sleep-disordered breathing as a risk factor for hypertension, Arch Intern Med, 157, 1746, 10.1001/archinte.157.15.1746

Peppard, 2000, Prospective study of the association between sleep disordered breathing and hypertension, N Engl J Med, 342, 1378, 10.1056/NEJM200005113421901

Nieto, 2000, Association of sleep disordered breathing, sleep apnea and hypertension in a large community-based study, JAMA, 283, 1829, 10.1001/jama.283.14.1829

De Olazabal, 1982, Disordered breathing and hypoxia during sleep in coronary artery disease, Chest, 82, 548, 10.1378/chest.82.5.548

Hung, 1990, Association of sleep apnoea with myocardial infarction in men, Lancet, 336, 261, 10.1016/0140-6736(90)91799-G

Saito, 1991, Sleep apnea in patients with acute myocardial infarction, Am J Respir Crit Care Med, 19, 938, 10.1097/00003246-199107000-00019

Mooe, 1996, Sleep-disordered breathing in men with coronary artery disease, Chest, 109, 659, 10.1378/chest.109.3.659

Bassetti, 1996, Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients, Neurology, 47, 1167, 10.1212/WNL.47.5.1167

Xie, 2000, Neurocirculatory consequences of intermittent asphyxia in humans, J Appl Physiol, 89, 1333, 10.1152/jappl.2000.89.4.1333

Leuenberger, 1995, Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxaemia, J Appl Physiol, 79, 581, 10.1152/jappl.1995.79.2.581

Somers, 1995, Sympathetic neural mechanisms in obstructive sleep apnea, J Clin Invest, 96, 1897, 10.1172/JCI118235

Carlson, 1993, Augmented resting sympathetic activity in awake patients with obstructive sleep apnea, Chest, 103, 1763, 10.1378/chest.103.6.1763

Narkiewicz, 1999, Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea, Circulation, 99, 1183, 10.1161/01.CIR.99.9.1183

Carlson, 1996, Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea, J Hypertens, 14, 577, 10.1097/00004872-199605000-00006

Imadojemu, 2002, Obstructive apnea during sleep is associated with peripheral vasoconstriction, Am J Respir Crit Care Med, 165, 61, 10.1164/ajrccm.165.1.2009062

Dean, 1993, Possible atherogenic effects of hypoxia during obstructive sleep apnea (Supplement: 2. Natural History of Sleep Apnea), Sleep, 16, S15, 10.1093/sleep/16.suppl_8.S15

Prabhakar, 2001, Physiologic and genomic consequences of intermittent hypoxia. Invited review: Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms, J Appl Physiol, 90, 1986, 10.1152/jappl.2001.90.5.1986

Droge, 2002, Free radicals in the physiological control of cell function, Physiol Rev, 82, 47, 10.1152/physrev.00018.2001

Babior, 2000, Phagocytes and oxidative stress, Am J Med, 109, 33, 10.1016/S0002-9343(00)00481-2

McCord, 2000, The evolution of free radicals and oxidative stress, Am J Med, 108, 652, 10.1016/S0002-9343(00)00412-5

Sen, 2000, Cellular thiols and redox-regulated signal transduction, Curr Top Cell Regul, 36, 1, 10.1016/S0070-2137(01)80001-7

Halliwell, 1990, Role of free radicals and catalytic metal ions in human disease: an overview, Meth Enzymol, 186, 1, 10.1016/0076-6879(90)86093-B

Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly, Am J Physiol, 271, C1421, 10.1152/ajpcell.1996.271.5.C1424

Dureanteau, 1998, Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes, J Biol Chem, 273, 11619, 10.1074/jbc.273.19.11619

Bouaziz, 2002, Mitocondrial respiratory chain as a new target for anti-ischemic molecules, Eur J Pharmacol, 441, 35, 10.1016/S0014-2999(02)01490-5

Sanders, 1993, Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport, J Clin Invest, 91, 46, 10.1172/JCI116198

Chandel, 1998, Mitochondrial reactive oxygen species trigger hypoxia-induced transcription, Procl Natl Acad Sci USA, 95, 11715, 10.1073/pnas.95.20.11715

Schulz, 2000, Enhanced release of superoxide form polymorphonuclear neutrophils in obstructive sleep apnea, Am J Respir Crit Care Med, 162, 566, 10.1164/ajrccm.162.2.9908091

Dyugovskaya, 2002, Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients, Am J Respir Crit Care Med, 165, 934, 10.1164/ajrccm.165.7.2104126

Mohazzab, 1994, NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium, Am J Physiol, 266, H2568

Rajogopalan, 1996, Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone, J Clin Invest, 97, 1916, 10.1172/JCI118623

Griendling, 2000, NAD(P)H oxidase. Role in cardiovascular biology and disease, Circ Res, 86, 494, 10.1161/01.RES.86.5.494

Barcelo, 2001, Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms, Eur Respir J, 17, 728, 10.1183/09031936.01.17407280

Marshall, 1996, Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction, Am J Resp Cell Mol Biol, 15, 633, 10.1165/ajrcmb.15.5.8918370

Fletcher, 1999, Renin activity and blood pressure in response to chronic episodic hypoxia, Hypertension, 34, 309, 10.1161/01.HYP.34.2.309

Fletcher, 2001, Physiological and genomic consequences of intermittent hypoxia. Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure, J Appl Physiol, 90, 1600, 10.1152/jappl.2001.90.4.1600

Fletcher, 2002, Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system, J Appl Physiol, 92, 627, 10.1152/japplphysiol.00152.2001

McCord, 1985, Oxygen derived free radicals in post ischemic tissue injury, New Engl J Med, 312, 159, 10.1056/NEJM198501173120305

Bolli, 1989, Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog, Proc Natl Acad Sci USA, 86, 4695, 10.1073/pnas.86.12.4695

Bolli, 1989, Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury, Circ Res, 65, 607, 10.1161/01.RES.65.3.607

Villari, 1993, The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts, Am Heart J, 125, 11, 10.1016/0002-8703(93)90051-A

Jolly, 1984, Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase, Circ Res, 54, 277, 10.1161/01.RES.54.3.277

Terada, 1992, Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischaemia-reperfusion, Am J Physiol, 263, L394

Terada, 1992, Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity, Proc Natl Acad Sci USA, 89, 3362, 10.1073/pnas.89.8.3362

Findley, 1988, Plasma adenosine and hypoxaemia in patients with sleep apnea, J Appl Physiol, 64, 556, 10.1152/jappl.1988.64.2.556

Mann, 1986, Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma, J Appl Physiol, 61, 1667, 10.1152/jappl.1986.61.5.1667

Sollevi, 1986, Cardiovascular effects of adenosine in man; possible clinical implications, Prog Neurobiol, 27, 319, 10.1016/0301-0082(86)90005-5

Eldridge, 1985, Antagonism by theophylline of respirator inhibition induced by adenosine, J Appl Physiol, 59, 1428, 10.1152/jappl.1985.59.5.1428

Mueller, 1984, Attempted anta-gonism of adenosine analogue induced depression of respiration, Pharmacol Biochem Behav, 21, 289, 10.1016/0091-3057(84)90228-4

Hasday, 1987, Nocturnal increase of urinary uric acid: creatinine ratio. A biochemical correlate of sleep-associated hypoxaemia, Am Rev Respir Dis, 135, 534

McKeon, 1990, Urinary uric acid: creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea, Am Rev Respir Dis, 142, 8, 10.1164/ajrccm/142.1.8

Braghiroli, 1993, Overnight urinary uric acid: Creatinine ratio for detection of sleep hypoxaemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure, Am Rev Respir Dis, 148, 173, 10.1164/ajrccm/148.1.173

Sahebjani, 1998, Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure, Chest, 113, 1604, 10.1378/chest.113.6.1604

Semenza, 2000, Oxygen-regulated transcription factors and their role in pulmonary disease, Respir Res, 1, 159, 10.1186/rr27

Piacentini, 1999, Altered gene expression during hypoxia and reoxygenation of the heart, Pharmacol Ther, 83, 21, 10.1016/S0163-7258(99)00010-8

Yuan, 2001, Activation of HIF-2a by intermittent hypoxia requires CaMKII (Abstract), FASEB J, 15, A154

Imagawa, 2001, Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome, Blood, 98, 1255, 10.1182/blood.V98.4.1255

Schulz, 2002, Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia, Am J Respir Crit Care Med, 165, 67, 10.1164/ajrccm.165.1.2101062

Gozal, 2002, Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea, Sleep, 25, 59, 10.1093/sleep/25.1.59

Lavie, 2002, Plasma Vascular Endothelial Growth Factor (VEGF) in sleep apnea syndrome: effects of nCPAP treatment, Am J Respir Crit Care Med, 165, 1624, 10.1164/rccm.20110-040OC

Schultz, 1999, Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation, Circulation, 100, 547, 10.1161/01.CIR.100.5.547

Gunsilius, 2002, Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome. (Letter to Editor), Blood, 99, 393, 10.1182/blood.V99.1.393

Webb, 1998, Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease, Clin Sci, 94, 395, 10.1042/cs0940395

Carlson, 1992, Secondary polycythaemia associated with nocturnal apnoea – a relationship not mediated by erythropoietin?, J Intern Med, 231, 381, 10.1111/j.1365-2796.1992.tb00948.x

Pokala, 1995, Erythropoietin response in subjects with obstructive sleep apnea, Am J Respir Crit Care Med, 151, 1862, 10.1164/ajrccm.151.6.7767532

Cahan, 1992, Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients, J Appl Physiol, 72, 2112, 10.1152/jappl.1992.72.6.2112

Cahan, 1995, Erythropoietin levels with treatment of obstructive sleep apnea, J Appl Physiol, 79, 1278, 10.1152/jappl.1995.79.4.1278

Knaupp, 1992, Erythropoietin response to acute normobaric hypoxia in humans, J Appl Physiol, 73, 837, 10.1152/jappl.1992.73.3.837

Ehlenz, 1991, Renal excretion of endothelin in obstructive sleep apnea syndrome, 217, 226

Saarelainen, 1997, Circulating endothelin-1 in obstructive sleep apnoea, Endothelium, 5, 115, 10.3109/10623329709079869

Phillips, 1999, Effects of obstructive sleep apnea on endolethelin-1 and blood pressure, J Hypertens, 17, 61, 10.1097/00004872-199917010-00010

Trakada, 2001, Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhaemoglobin desaturation, Respiration, 68, 134, 10.1159/000050482

Tahawi, 2001, Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats, J Appl Physiol, 90, 2007, 10.1152/jappl.2001.90.5.2007

Kanagy, 2001, Role of endothelin in intermittent hypoxia-induced hypertension, Hypertension, 37, 511, 10.1161/01.HYP.37.2.511

Grimpen, 2000, Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea, Eur Respir J, 15, 320, 10.1034/j.1399-3003.2000.15b17.x

Saarelainen, 2000, Circulating endothelin-1 and obstructive sleep apnoea, Eur Respir J, 16, 794, 10.1034/j.1399-3003.2000.16a32.x

Chin, 2001, Increase in bilirubin levels of patients with obstructive sleep apnea in the morning – a possible explanation of induced heme oxygenase-1, Sleep, 24, 218, 10.1093/sleep/24.2.218

Vgontzas, 1997, Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbances and obesity, J Clin Endocrinol Metab, 82, 1313, 10.1210/jc.82.5.1313

Vgontzas, 2000, Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia, J Clin Endocrinol Metab, 85, 1151, 10.1210/jc.85.3.1151

Entzian, 1996, Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines, Am J Respir Crit Care Med, 153, 1080, 10.1164/ajrccm.153.3.8630548

Chin, 2000, Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome, Am J Med, 109, 562, 10.1016/S0002-9343(00)00580-5

Ohga, 1999, Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome, J Appl Physiol, 87, 10, 10.1152/jappl.1999.87.1.10

El-Solh, 2002, Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea, Chest, 121, 1541, 10.1378/chest.121.5.1541

Sen, 1998, Redox signaling and the emerging therapeutic potential of thiol antioxidants, Biochem Pharmacol, 55, 1747, 10.1016/S0006-2952(97)00672-2

Noguchi, 1997, Heat shock protein 72 level decreases during sleep in patients with obstructive sleep apnea syndrome, Am J Respir Crit Care Med, 155, 1316, 10.1164/ajrccm.155.4.9105073

Lavie, 1998, Production of heat shock protein 70 by peripheral blood monocytes from patients with sleep apnea syndrome, J Sleep Res, 7, 150

Ghandour, 1999, Expression of heat shock proteins in obstructive sleep apnea syndrome, Sleep, 22, S331

Forgione, 2000, Roles of endothelial dysfunction in coronary artery disease, Curr Opin Cardiol, 15, 409, 10.1097/00001573-200011000-00007

Grisham, 1998, Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease, Free Radic Biol Med, 25, 404, 10.1016/S0891-5849(98)00094-X

Walzog, 2000, Adhesion molecules: the path to a new understanding of acute inflammation, News Physiol Sci, 15, 107

Panes, 1998, Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease, Gastroenterology, 114, 1066, 10.1016/S0016-5085(98)70328-2

Tailor, 2000, Role of adhesion molecules in vascular regulation and damage, Curr Hypertens Rep, 2, 78, 10.1007/s11906-000-0063-6

Rairigh, 2000, Role of neuronal nitric oxide synthase in regulation of vascular and ductus arteriosus tone in the ovine fetus, Am Physiol Lung Cell Mol Physiol, 278, L105, 10.1152/ajplung.2000.278.1.L105

Rairigh, 1998, Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus, J Clin Invest, 101, 15, 10.1172/JCI1228

Hoffmann, 2001, Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism, J Cell Physiol, 188, 33, 10.1002/jcp.1092

Phelan, 1996, Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells, J Cell Physiol, 167, 469, 10.1002/(SICI)1097-4652(199606)167:3<469::AID-JCP11>3.0.CO;2-#

Faller, 1999, Endothelial cell responses to hypoxic stress, Clin Exp Pharmacol Physiol, 26, 74, 10.1046/j.1440-1681.1999.02992.x

Schulz, 2000, Decreased plasma levels of nitric oxide derivative in obstructive sleep apnoea: response to nCPAP therapy, Thorax, 55, 1046, 10.1136/thorax.55.12.1046

Ip, 2000, Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure, Am J Respir Crit Care Med, 162, 2166, 10.1164/ajrccm.162.6.2002126

Carlson, 1997, Increased plasma concentration of ADMA a naturally occurring nitric oxide synthesis inhibitor in OSA patients, Am J Respir Crit Care Med, 155, A869

Ross, 1999, Atherosclerosis – an inflammatory disease, New Eng J Med, 340, 115, 10.1056/NEJM199901143400207

Steinberg, 1997, Low density lipoprotein oxidation and its pathological significance, J Biol Chem, 272, 20963, 10.1074/jbc.272.34.20963

Koo, 1988, Enhanced macrophage uptake of low density lipoprotein after self-aggregation, Arteriosclerosis, 8, 348, 10.1161/01.ATV.8.4.348

Navab, 1996, The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture, Arterioscler Thromb Vasc Biol, 16, 831, 10.1161/01.ATV.16.7.831

Morel, 1983, Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid, J Lipid Res, 24, 1070, 10.1016/S0022-2275(20)37921-9

Griendling, 1997, Oxidative stress and cardiovascular disease, Circulation, 96, 3264

Wali, 1998, Susceptibility of LDL to oxidative stress in obstructive sleep apnea, Sleep, 21, 290

Saarelainen, 1999, Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea, Clin Chem Lab Med, 37, 517, 10.1515/CCLM.1999.083

Salonen, 1992, Autoantibody against oxidized LDL and progression of carotid atherosclerosis, Lancet, 339, 899, 10.1016/0140-6736(92)90926-T

Barcelo, 2000, Abnormal lipid peroxidation in patients with sleep apnoea, Eur Respir J, 16, 644, 10.1034/j.1399-3003.2000.16d13.x

McCully, 1969, Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis, Am J Pathol, 56, 111

Graham, 1997, Plasma homocysteine as a risk factor for vascular disease; The European concerted action project, JAMA, 277, 1775, 10.1001/jama.277.22.1775

Boushey, 1995, A qualitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes, JAMA, 274, 1049, 10.1001/jama.274.13.1049

Nygard, 1997, Plasma homocysteine levels and mortality in patients with coronary artery disease, N Engl J Med, 337, 230, 10.1056/NEJM199707243370403

Lentz, 1996, Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia, J Clin Invest, 98, 24, 10.1172/JCI118771

Tawakol, 1997, Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans, Circulation, 95, 1119, 10.1161/01.CIR.95.5.1119

Bellamy, 1998, Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults, Circulation, 1848, 10.1161/01.CIR.98.18.1848

Chambers, 1999, Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy, Circulation, 99, 1156, 10.1161/01.CIR.99.9.1156

Selhub, 1995, Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis, N Engl J Med, 332, 286, 10.1056/NEJM199502023320502

Loscalzo, 1996, The oxidant stress of hyperhomocyst(e)inemia, J Clin Invest, 98, 5, 10.1172/JCI118776

Heinecke, 1987, The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells, J Biol Chem, 262, 10098, 10.1016/S0021-9258(18)61082-8

Eberhardt, 2000, Endothelial dysfunction in a murine model of mild hyperholocyst(e)inemia, J Clin Invest, 106, 483, 10.1172/JCI8342

Lavie, 2001, Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity, Chest, 120, 900, 10.1378/chest.120.3.900

Joannides, 1995, Nitric oxide is responsible for flow dependent dilation of human peripheral conduit arteries in vivo, Circulation, 91, 1314, 10.1161/01.CIR.91.5.1314

Celermajer, 1992, Non invasive detection of endothelial dysfunction in children and in adults at risk of atherosclerosis, Lancet, 340, 1111, 10.1016/0140-6736(92)93147-F

Kato, 2000, Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea, Circulation, 102, 2607, 10.1161/01.CIR.102.21.2607

Kraiczi, 2001, Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxaemia during sleep, Chest, 119, 1085, 10.1378/chest.119.4.1085